Pharbinex Tablet
Product Images NDC 73057-379

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Pharbinex (NDC 73057-379). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ulai Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ulai Pharbinex 30ct. Label (Ulai Pharbinex 30ct. Label)

Pharbinex Guaifenesin 400mg immediate release expectorant tablets packaging label displaying 30 tablets. The label notes the product is manufactured in the USA by Ulai Health LLC. It includes the active ingredient guaifenesin 400mg per tablet and states the product's purpose as an expectorant. The label also displays a tamper-evident warning, drug facts, warnings, directions, inactive ingredients, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.